At Novartis, our mission is to help improve people's lives not only by researching and developing innovative prescription medicines, but most importantly, by providing access programs for patients who cannot afford their Novartis prescriptions.
Millions of patients around the world benefit from Novartis initiatives that include: drug donation and research programs; combating neglected diseases such as malaria, tuberculosis, and leprosy in developing nations; and providing patient assistance programs that help cancer patients receive ground-breaking treatments.
In 2015, Novartis provided over $706 million in free medication to more than 42,000 patients in the United States through the Novartis Patient Assistance Foundation, Inc. We also offer support programs and services to eligible patients who have prescription drug coverage.
See how Patient Assistance NOW helps patients like you afford your medicine
Outside of the US, Novartis has partnered with the World Health Organization (WHO) and other agencies and nongovernmental organizations to pioneer access programs. Through multilateral institutions and public-private partnerships, we are donating our antimalarial drug globally without profit. We also supply free treatment to help eliminate leprosy through a partnership with WHO. Click here to learn more.